Key result
FIRM-guided rotor ablation followed by conventional PVI resulted in 76.9% of patients with recurrent nonparoxysmal AF remaining free from AF/AT at 12 months.
Why the study?
Does FIRM-guided rotor ablation combined with conventional PVI improve freedom from AF/AT in patients with recurrent nonparoxysmal AF?
Cohort (n=58)
Does FIRM-guided rotor ablation combined with conventional PVI improve freedom from AF/AT in patients with recurrent nonparoxysmal AF?
FIRM-guided rotor ablation combined with conventional PVI demonstrates a high rate of freedom from arrhythmia at 12 months in patients with recurrent nonparoxysmal AF who previously failed conventional ablation.
Answers are grounded in this paper and cite their sources.
May support FIRM plus PVI in recurrent nonparoxysmal AF after failed ablation; leaves open efficacy confirmation in randomized trials.
INTRODUCTION: A patient-tailored ablation approach focused on the elimination of both pulmonary vein triggers as well as substrate drivers may result in favorable outcomes in recurrent persistent AF patients. OBJECTIVE: We evaluated the long-term outcomes of rotor ablation combined with conventional pulmonary vein isolation (PVI) in patients with recurrent nonparoxysmal AF. METHODS: Fifty-eight consecutive patients underwent FIRM-guided rotor ablation followed by conventional PVI for the treatment of recurrent nonparoxysmal AF. A software algorithm was used to display rotational activity at rotor sites by creating propagation maps from unipolar electrograms recorded using a 64-electrode basket catheter. These rotor sites were targeted for ablation, followed by conventional PVI. RESULTS: All patients had nonparoxysmal AF (83% longstanding persistent) and a previously failed conventional ablation procedure. Stable rotors were identified in all patients (mean of 3.0 ± 1.6 per patient), with 55.2% having right atrial rotors and 96.6% left atrial rotors, respectively. Complications occurred in 5.2% of patients, none related to the FIRM procedure. The median follow-up was 12 months. At 6 and 12 months of follow-up, 73.2% and 76.9% of patients remained free from AF/AT, respectively. Excluding 2 patients who underwent a successful redo ablation procedure/electrical cardioversion, at 12 months of follow-up, 69.2% were free from any AF/AT and 73.1% were free from AF after a single FIRM-guided ablation procedure. CONCLUSION: A high degree of success was observed in this cohort of primarily longstanding persistent AF patients treated for recurrent AF with FIRM-guided rotor ablation. Prospective randomized controlled trials are needed.
No takes yet. Share an insight, caveat, or question.
Spitzer et al. (2016) conducted a cohort in recurrent nonparoxysmal atrial fibrillation (n=58). FIRM-guided rotor ablation followed by conventional PVI was evaluated on freedom from AF/AT at 12 months. FIRM-guided rotor ablation followed by conventional PVI resulted in 76.9% of patients with recurrent nonparoxysmal AF remaining free from AF/AT at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: